AstraZeneca $360m Irish manufacturing investment
21 September 2021 07:00 BST AstraZeneca to invest $360m in advanced manufacturing facility in Ireland Investment will transform development and commercialisation of new medicines AstraZeneca is planning on establishing a next-generation active pharmaceutical ingredient (API) manufacturing facility for small molecules near Dublin, Ireland to ensure the Company's global supply network is fit for future growth. The new plant will allow for late-stage development and early commercial supply, adopting state of the art process technology and digital innovation that is designed to meet